Skip to main content

Table 1 Study population characteristics

From: The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications

Parameter

Baseline value

Age [years, mean (SD)]

54.8 (11.0)

Female sex (%)

39.8

Age at diagnosis of type-2 diabetes [years, mean (SD)]

49.8 (11.6)

Currently smoking (%)

24.9

HbA1c [%, median (IQR)]

7.4 (6.6–8.6)

Systolic blood pressure [mmHg, mean(SD)]

145 (21)

Total cholesterol/HDL cholesterol ratio [median (IQR)]

4.6 (3.7–6.1)

NT-proBNP [pg/mL, median (IQR)]

92 (44–216)

MMP-3 [ng/mL, median (IQR)]

12.4 (8.1–17.3)

Osteopontin [ng/ml, median (IQR)]

17.0 (13.3–21.9)

  1. Patient characteristics of the 389 patients without prior cardiovascular disease history in the SMART cohort
  2. SD standard deviation, IQR interquartile range